Hennion & Walsh Asset Management, Inc. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 157 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
Hennion & Walsh Asset Management, Inc. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$73
-32.4%
52,339
-3.2%
0.00%
-42.9%
Q4 2022$108
-99.9%
54,070
-12.7%
0.01%
-12.5%
Q3 2022$125,000
-39.6%
61,940
-4.9%
0.01%
-38.5%
Q2 2022$207,000
-24.7%
65,124
-1.4%
0.01%
-13.3%
Q1 2022$275,000
-18.6%
66,049
-6.3%
0.02%
-11.8%
Q4 2021$338,000
-8.2%
70,513
+2.3%
0.02%
-10.5%
Q3 2021$368,000
+49.0%
68,915
+43.1%
0.02%
+46.2%
Q2 2021$247,00048,1700.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders